Underwriting Agreement Sample Contracts

Share Cite Term
Link

Embed (HTML)
Towerstream Corporation Underwriting Agreement (October 19th, 2017)

Joseph Gunnar & Co., LLCAs Representative of the several Underwriters named on Schedule 1 attached hereto30 Broad Street, 11th Fl

Haymaker Acquisition Corp. – Haymaker Acquisition Corp. Underwriting Agreement (October 19th, 2017)

The undersigned, Haymaker Acquisition Corp., a Delaware corporation (the "Company"), hereby confirms its agreement with Cantor Fitzgerald & Co. ("Cantor Fitzgerald" or the "Representative") and with the other underwriters named on Schedule A hereto (if any), for which the Representative is acting as representative (the Representative and such other underwriters being collectively referred to herein as the "Underwriters" or, each underwriter individually, an "Underwriter") as follows:

CM Seven Star Acquisition Corp – 15,000,000 Units CM SEVEN STAR ACQUISITION CORPORATION UNDERWRITING AGREEMENT (October 19th, 2017)
NanoVibronix, Inc. – Nanovibronix, Inc. Underwriting Agreement (October 18th, 2017)

The undersigned, NanoVibronix, Inc., a corporation formed under the laws of the State of Delaware (the "Company"), hereby confirms its agreement (this "Agreement") with Dawson James Securities, Inc. (the "Representative") and with the other underwriters, if any, named on Schedule 1 hereto for which the Representative is acting as representative (the Representative and such other underwriters, if any, being collectively called the "Underwriters" or, individually, an "Underwriter") as follows:

UBS Commercial Mortgage Trust 2017-C4 – UBS COMMERCIAL MORTGAGE TRUST 2017-C4 COMMERCIAL MORTGAGE PASS-THROUGH CERTIFICATES, SERIES 2017-C4 UNDERWRITING AGREEMENT as of September 29, 2017 (October 18th, 2017)
Mosaic Acquisition Corp. – 30,000,000 Units1 Mosaic Acquisition Corp. UNDERWRITING AGREEMENT (October 13th, 2017)
Underwriting Agreement (October 13th, 2017)

Tandem Diabetes Care, Inc., a Delaware corporation (the "Company"), confirms its agreement with Oppenheimer & Co. Inc. ("Oppenheimer") and each of the other Underwriters named in Schedule A hereto (collectively, the "Underwriters," which term shall also include any underwriter substituted as hereinafter provided in Section 10 hereof), for whom Oppenheimer is acting as representative (in such capacity, the "Representative"), with respect to the sale by the Company and the purchase by the Underwriters, acting severally and not jointly, of the respective numbers of (x) shares (the "Shares") of Common Stock, par value $0.001 per share, of the Company ("Common Stock") set forth in Schedule A hereto, (y) Series A warrants to purchase up to an aggregate of 4,630,000 shares of Common Stock (the "Series A Warrants") and (z) Series B warrants to purchase up to an aggregate of 4,630,000 shares of Common Stock (the "Series B Warrants" and together with the Series A Warrants, the "Warrants") set f

Haymaker Acquisition Corp. – UNDERWRITING AGREEMENT Between HAYMAKER ACQUISITION CORP. And CANTOR FITZGERALD & CO. Dated: ____________, 2017 HAYMAKER ACQUISITION CORP. UNDERWRITING AGREEMENT (October 13th, 2017)

The undersigned, Haymaker Acquisition Corp., a Delaware corporation (the "Company"), hereby confirms its agreement with Cantor Fitzgerald & Co. ("Cantor Fitzgerald" or the "Representative") and with the other underwriters named on Schedule A hereto (if any), for which the Representative is acting as representative (the Representative and such other underwriters being collectively referred to herein as the "Underwriters" or, each underwriter individually, an "Underwriter") as follows:

EpiCept Corporation – Immune Pharmaceuticals Inc. Underwriting Agreement (October 11th, 2017)
OptiNose, Inc. – OptiNose, Inc. UNDERWRITING AGREEMENT (October 11th, 2017)
Anaptysbio Inc – [] Shares ANAPTYSBIO, INC. Common Stock, Par Value $0.001 Per Share UNDERWRITING AGREEMENT (October 10th, 2017)
Genprex, Inc. – Genprex, Inc. Underwriting Agreement (October 10th, 2017)
UNDERWRITING AGREEMENT Tronox Limited 19,500,000 Class a Ordinary Shares Underwriting Agreement (October 10th, 2017)
Loton, Corp – Common Stock, $0.001 Par Value Per Share Underwriting Agreement (October 6th, 2017)
Black Ridge Acquisition Corp. – 12,000,000 Units BLACK RIDGE ACQUISITION CORP. UNDERWRITING AGREEMENT (October 5th, 2017)
Paramount Gold Nevada Corp. – Underwriting Agreement (October 5th, 2017)
Ritter Pharmaceuticals Inc – UNDERWRITING AGREEMENT Between RITTER PHARMACEUTICALS, INC. And AEGIS CAPITAL CORP., as Representative of the Several Underwriters RITTER PHARMACEUTICALS, INC. UNDERWRITING AGREEMENT (October 4th, 2017)

The undersigned, Ritter Pharmaceuticals, Inc., a corporation formed under the laws of the State of Delaware (the "Company"), hereby confirms its agreement (this "Agreement") with Aegis Capital Corp. (hereinafter referred to as "you" (including its correlatives) or the "Representative") and with the other underwriters named on Schedule 1 hereto for which the Representative is acting as representative (the Representative and such other underwriters being collectively called the "Underwriters" or, individually, an "Underwriter") as follows:

5,000,000 Shares NewLink Genetics Corporation UNDERWRITING AGREEMENT (October 4th, 2017)

Introductory. NewLink Genetics Corporation, a Delaware corporation (the "Company"), proposes to issue and sell to the several underwriters named in Schedule A (the "Underwriters") an aggregate of 5,000,000 shares of its common stock, par value $0.01 per share (the "Shares"). The 5,000,000 Shares to be sold by the Company are called the "Firm Shares." In addition, the Company has granted to the Underwriters an option to purchase up to an additional 750,000 Shares as provided in Section 2. The additional 750,000 Shares to be sold by the Company pursuant to such option are called the "Optional Shares." The Firm Shares and, if and to the extent such option is exercised, the Optional Shares are collectively called the "Offered Shares." Merrill Lynch, Pierce, Fenner & Smith Incorporated ("Merrill Lynch") and Stifel, Nicolaus & Company, Incorporated. ("Stifel") have agreed to act as representatives of the several Underwriters (in such capacity, the "Representatives") in connection with the of

21,250,000 Shares of Common Stock of Jaguar Health, Inc. Underwriting Agreement (October 3rd, 2017)
FEDERAL REALTY INVESTMENT TRUST 6,000,000 Depositary Shares Each Representing 1/1000 Interest in a Share of 5.000% Series C Cumulative Redeemable Preferred Shares (Liquidation Preference Equivalent to $25 Per Share) Underwriting Agreement (September 29th, 2017)
CM Seven Star Acquisition Corp – 15,000,000 Units CM SEVEN STAR ACQUISITION CORPORATION UNDERWRITING AGREEMENT (September 29th, 2017)
Citigroup Commercial Mortgage Trust 2017-P8 – CITIGROUP COMMERCIAL MORTGAGE SECURITIES INC. CITIGROUP COMMERCIAL MORTGAGE TRUST 2017-P8 COMMERCIAL MORTGAGE PASS-THROUGH CERTIFICATES, SERIES 2017-P8 Underwriting Agreement Dated as of September 18, 2017 (September 29th, 2017)

Citigroup Commercial Mortgage Securities Inc., a Delaware corporation (the "Company"), proposes to cause the issuance of its Citigroup Commercial Mortgage Trust 2017-P8, Commercial Mortgage Pass-Through Certificates, Series 2017-P8 (the "Certificates"), in multiple classes, under a Pooling and Servicing Agreement (the "Pooling and Servicing Agreement"), dated as of September 1, 2017, between the Company, as depositor, Wells Fargo Bank, National Association, as master servicer (the "Master Servicer"), KeyBank National Association, as special servicer (the "Special Servicer"), Pentalpha Surveillance LLC, as operating advisor (in such capacity, the "Operating Advisor") and asset representations reviewer (in such capacity, the "Asset Representations Reviewer"), Citibank, N.A., as certificate administrator (the "Certificate Administrator"), and Wilmington Trust, National Association, as trustee (the "Trustee"), and proposes to sell the classes of Certificates specified on Schedule I hereto

Westlake Chemical Partners LP – WESTLAKE CHEMICAL PARTNERS LP 4,500,000 Common Units Representing Limited Partner Interests UNDERWRITING AGREEMENT (September 28th, 2017)
Bank 2017-Bnk7 – BANK 2017-Bnk7 COMMERCIAL MORTGAGE PASS-THROUGH CERTIFICATES, SERIES 2017-Bnk7 UNDERWRITING AGREEMENT as of September 19, 2017 (September 28th, 2017)

Wells Fargo Commercial Mortgage Securities, Inc., a North Carolina corporation (the "Depositor"), intends to issue its BANK 2017-BNK7, Commercial Mortgage Pass-Through Certificates, Series 2017-BNK7 (the "Certificates"), in twenty-two (22) classes and interests (each, a "Class") as designated in the Prospectus (as defined below). Pursuant to this underwriting agreement (the "Agreement"), the Depositor further proposes to sell to Wells Fargo Securities, LLC ("Wells Fargo Securities"), Merrill Lynch, Pierce, Fenner & Smith Incorporated ("MLPF&S"), Morgan Stanley & Co. LLC ("MS&Co.") and Academy Securities, Inc. ("Academy" and, collectively with Wells Fargo Securities, MLPF&S and MS&Co., the "Underwriters" and each, individually, an "Underwriter") the Certificates set forth in Schedule I hereto (the "Registered Certificates") in the respective original principal amounts and notional amounts set forth in Schedule I. The Certificates represent in the aggregate the entire beneficial ownershi

Towerstream Corporation Underwriting Agreement (September 26th, 2017)

Joseph Gunnar & Co., LLCAs Representative of the several Underwriters named on Schedule 1 attached hereto30 Broad Street, 11th Fl

Oasis Midstream Partners LP – 7,500,000 Common Units Representing Limited Partner Interests OASIS MIDSTREAM PARTNERS LP UNDERWRITING AGREEMENT September 20, 2017 (September 22nd, 2017)

Oasis Midstream Partners LP (the Partnership), a Delaware limited partnership, proposes to issue and sell to the several Underwriters named in Schedule I hereto (the Underwriters) 7,500,000 common units (the Firm Units), each representing a limited partner interest in the Partnership (the Common Units). The Partnership also proposes to issue and sell to the several Underwriters not more than an additional 1,125,000 Common Units (the Additional Units) if and to the extent that Morgan Stanley & Co. LLC, as sole representative of the Underwriters (the Representative), shall have determined to exercise, on behalf of the Underwriters, the right to purchase such Additional Units granted to the Underwriters in Section 2 hereof. The Firm Units and the Additional Units are hereinafter collectively referred to as the Units.

7,692,308 Shares Iovance Biotherapeutics, Inc. UNDERWRITING AGREEMENT (September 21st, 2017)
Social Capital Hedosophia Holdings Corp. – 60,000,000 Units Social Capital Hedosophia Holdings Corp. UNDERWRITING AGREEMENT (September 18th, 2017)
Crosstex Energy, L.P. – EnLink Midstream Partners, LP 6.000% Series C Fixed-To-Floating Rate Cumulative Redeemable Perpetual Preferred Units UNDERWRITING AGREEMENT (September 18th, 2017)
Colony NorthStar, Inc. – COLONY NORTHSTAR, INC. (A Maryland Corporation) 11,000,000 Shares of 7.125% Series J Cumulative Redeemable Perpetual Preferred Stock Date: September 13, 2017 UNDERWRITING AGREEMENT (September 15th, 2017)
General Motors Financial Company, Inc. 1,000,000 Shares of Fixed-To-Floating Rate Cumulative Perpetual Preferred Stock, Series a (Par Value $0.01 Per Share, Liquidation Preference $1,000.00 Per Share) UNDERWRITING AGREEMENT (September 15th, 2017)
Workhorse Group Inc. – Underwriting Agreement (September 14th, 2017)

Cowen and Company, LLC as Representative of the several Underwriters named in Schedule I hereto c/o Cowen and Company, LLC

33,500 Shares of Series C Convertible Preferred Stock Par Value $0.01 FUELCELL ENERGY, INC. UNDERWRITING AGREEMENT (September 8th, 2017)
Ibm Credit Llc – Underwriting Agreement (September 8th, 2017)

IBM Credit LLC, a Delaware limited liability company (the "Company"), proposes to sell to the underwriters named in Schedule II hereto (the "Underwriters"), for whom you are acting as representatives (the "Representatives"), the principal amount of its Securities identified in Schedule I hereto (the "Securities"), to be issued under an indenture to be dated as of September 8, 2017 (the "Indenture"), between the Company and The Bank of New York Mellon Trust Company, N.A., as trustee (the "Trustee"). If the firm or firms listed in Schedule II hereto include only the firm or firms listed in Schedule I hereto, then the terms "Underwriters" and "Representatives", as used herein shall each be deemed to refer to such firm or firms.

Genprex, Inc. – Genprex, Inc. Underwriting Agreement (September 8th, 2017)